Modulating caspase activity: Beyond the active site

Current Opinion in Structural Biology

Volumn 23, Issue 6, 2013, Pages 812-819

  Murray, Jeremy ^a   Renslo, Adam R ^b  

^a GENENTECH INC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE; CASPASE 6; DIMER; PROCASPASE 6; UNCLASSIFIED DRUG;

ALLOSTERISM; ALZHEIMER DISEASE; BINDING SITE; COMPLEX FORMATION; CRYSTAL STRUCTURE; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME CONFORMATION; ENZYME INHIBITION; ENZYME SUBSTRATE COMPLEX; HUNTINGTON CHOREA; MOLECULAR DOCKING; NERVE DEGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; CASPASES; CATALYTIC DOMAIN; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, QUATERNARY; SMALL MOLECULE LIBRARIES;

EID: 84888832108     PISSN: 0959440X     EISSN: 1879033X     Source Type: Journal    
DOI: 10.1016/j.sbi.2013.10.002     Document Type: Review

References (23)

1. McIlwain D.R., Berger T., Mak T.W. Caspase functions in cell death and disease. Cold Spring Harb Perspect Biol 2013, 5:a0086.
2. Hacker H.G., Sisay M.T., Gutschow M. Allosteric modulation of caspases. Pharmacol Ther 2011, 132:180-195.
3. MacKenzie S.H., Schipper J.L., Clark A.C. The potential for caspases in drug discovery. Curr Opin Drug Discov Dev 2010, 13:568-576.
4. Garcia-Calvo M., Peterson E.P., Leiting B., Ruel R., Nicholson D.W., Thornberry N.A. Inhibition of human caspases by peptide-based and macromolecular inhibitors. J Biol Chem 1998, 273:32608-33261.
5. Wang X.J., Cao Q., Liu X., Wang K.T., Mi W., Zhang Y., Li L.F., LeBlanc A.C., Su X.D. Crystal structures of human caspase 6 reveal a new mechanism for intramolecular cleavage self-activation. EMBO Rep 2010, 11:841-847.
6. Thomsen N.D., Koerber J.T., Wells J.A. Structural snapshots reveal distinct mechanisms of procaspase-3 and -7 activation. Proc Natl Acad Sci USA 2013, 110:8477-8482.
7. Hardy J.A., Wells J.A. Searching for new allosteric sites in enzymes. Curr Opin Struct Biol 2004, 14:706-715.
8. Scheer J.M., Romanowski M.J., Wells J.A. A common allosteric site and mechanism in caspases. Proc Natl Acad Sci USA 2006, 103:7595-7600.
9. Datta D., Scheer J.M., Romanowski M.J., Wells J.A. An allosteric circuit in caspase-1. J Mol Biol 2008, 381:1157-1167.
10. Datta D., McClendon C.L., Jacobson M.P., Wells J.A. Substrate and inhibitor-induced dimerization and cooperativity in caspase-1 but not caspase-3. J Biol Chem 2013, 288:9971-9981.
11. Hardy J.A., Lam J., Nguyen J.T., O'Brien T., Wells J.A. Discovery of an allosteric site in the caspases. Proc Natl Acad Sci USA 2004, 101:12461-12466.
12. Murray J., Giannetti A.M., Steffek M., Gibbons P., Hearn B.R., Cohen F., Tam C., Pozniak C., Bravo B., Lewcock J.W., et al. Tailoring Small Molecules for an Allosteric Site on Procaspse-6. ChemMedChem 2013, in press.
13. Schipper J.L., MacKenzie S.H., Sharma A., Clark A.C. A bifunctional allosteric site in the dimer interface of procaspase-3. Biophys Chem 2011, 159:100-109.
14. Gao J., Wells J.A. Identification of specific tethered inhibitors for caspase-5. Chem Biol Drug Des 2012, 79:209-215.
15. Simon D.J., Weimer R.M., McLaughlin T., Kallop D., Stanger K., Yang J., O'Leary D.D., Hannoush R.N., Tessier-Lavigne M. A caspase cascade regulating developmental axon degeneration. J Neurosci 2012, 32:17540-17553.
16. LeBlanc A.C. Caspase-6 as a novel early target in the treatment of Alzheimer's disease. Eur J Neurosci 2013, 37:2005-2018.
17. Vickers C.J., Gonzalez-Paez G.E., Umotoy J.C., Cayanan-Garrett C., Brown S.J., Wolan D.W. Small-molecule procaspase activators identified using fluorescence polarization. Chembiochem 2013, 14:1419-1422.
18. Zorn J.A., Wille H., Wolan D.W., Wells J.A. Self-assembling small molecules form nanofibrils that bind procaspase-3 to promote activation. J Am Chem Soc 2011, 133:19630-19633.
19. Zorn J.A., Wolan D.W., Agard N.J., Wells J.A. Fibrils colocalize caspase-3 with procaspase-3 to foster maturation. J Biol Chem 2012 2012, 287:33781-33795.
20. Peterson Q.P., Goode D.R., West D.C., Ramsey K.N., Lee J.J., Hergenrother P.J. PAC-1 activates procaspase-3 in vitro through relief of zinc-mediated inhibition. J Mol Biol 2009, 388:144-158.
21. Feldman T., Kabaleeswaran V., Jang S.B., Antczak C., Djaballah H., Wu H., Jiang X. A class of allosteric caspase inhibitors identified by high-throughput screening. Mol Cell 2012, 47:585-595.
22. Stanger K., Steffek M., Zhou L., Pozniak C.D., Quan C., Franke Y., Tom J., Tam C., Krylova I., Elliott J.M., et al. Allosteric peptides bind a caspase zymogen and mediate caspase tetramerization. Nat Chem Biol 2012, 8:655-660.
23. Heise C.E., Murray J., Augustyn K.E., Bravo B., Chugha P., Cohen F., Giannetti A.M., Gibbons P., Hannoush R.N., Hearn B.R., et al. Mechanistic and structural understanding of uncompetitive inhibitors of caspase-6. PLoS ONE 2012, 7:e45086.